Verrica Pharmaceuticals Inc. (VRCA) Operating margin 2021–2025
Verrica Pharmaceuticals Inc. (VRCA) operating margin by fiscal year — reported operating income divided by reported revenue.
-34.2%FY2025 · since FY2021: -257.6% → -34.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -34.2% | +837.0 pp |
| FY2024 | -871.3% | +412.1 pp |
| FY2023 | -1283.4% | -1047.6 pp |
| FY2022 | -235.8% | +21.8 pp |
| FY2021 | -257.6% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VRCA financial trends
VRCA RevenueVRCA Net incomeVRCA Net marginVRCA Gross profitVRCA Gross marginVRCA Operating incomeVRCA Operating cash flowVRCA Free cash flowVRCA Capital expendituresVRCA Return on equityVRCA Stock buybacksVRCA Dividends paidVRCA Total assetsVRCA Total liabilitiesVRCA Shareholders’ equityVRCA overview →